IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 21 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $320,000 | -3.0% | 300,000 | 0.0% | 0.00% | – |
| Q1 2019 | $330,000 | +17.9% | 300,000 | 0.0% | 0.00% | – |
| Q4 2018 | $280,000 | -28.0% | 300,000 | 0.0% | 0.00% | – |
| Q3 2018 | $389,000 | -2.3% | 300,000 | 0.0% | 0.00% | – |
| Q2 2018 | $398,000 | +12.7% | 300,000 | 0.0% | 0.00% | – |
| Q1 2018 | $353,000 | +1.7% | 300,000 | 0.0% | 0.00% | – |
| Q4 2017 | $347,000 | -61.3% | 300,000 | -60.3% | 0.00% | -100.0% |
| Q3 2017 | $897,000 | -49.6% | 755,000 | -43.2% | 0.00% | -50.0% |
| Q2 2017 | $1,779,000 | -23.1% | 1,330,000 | -28.5% | 0.00% | 0.0% |
| Q1 2017 | $2,312,000 | -4.5% | 1,860,000 | -12.1% | 0.00% | 0.0% |
| Q4 2016 | $2,420,000 | -46.2% | 2,115,000 | -43.9% | 0.00% | -50.0% |
| Q3 2016 | $4,494,000 | -3.8% | 3,770,000 | -17.3% | 0.00% | -20.0% |
| Q2 2016 | $4,671,000 | – | 4,560,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 18,300,000 | $21,970,000 | 3.09% |
| Mohican Financial Management, LLC | 2,000,000 | $2,384,000 | 2.61% |
| LINDEN ADVISORS LP | 39,927,000 | $47,710,000 | 2.18% |
| Castle Creek Arbitrage, LLC | 9,000,000 | $10,753,000 | 1.10% |
| OAKTREE CAPITAL MANAGEMENT LP | 43,658,000 | $52,238,000 | 0.68% |
| Polar Asset Management Partners Inc. | 17,500,000 | $20,890,000 | 0.65% |
| WOLVERINE ASSET MANAGEMENT LLC | 29,228,000 | $34,936,000 | 0.52% |
| DAFNA Capital Management LLC | 600,000 | $717,000 | 0.50% |
| SSI INVESTMENT MANAGEMENT LLC | 4,700,000 | $5,603,000 | 0.50% |
| RWC Asset Management LLP | 5,000,000 | $6,003,000 | 0.37% |